Categorized | Stock Newsletters

New Explosive Announcement For Monday Nov. 22 HEME

Hi Everyone,



Some of our alerts this year have seen monumental gains!

Gains anywhere from 50% to even over 500% just within weeks!

We are excited to share a new pick that we think might be a GREAT opportunity for our members.

And our brand new pick is:



                                                            ** HEME **   

HEME has recently been experiencing
heavy accumulation. This could be a very bullish indicator!

At these levels we think HEME is showing strong upside potential.


The healthcare industry is one of the most important and most profitable industries in this world.

It is also one of the most fastest growing.

It is expected that healthcare spending in general could reach 4.5 trillion by 2019!

Last year nearly a whopping $2.5 trillion was spent on healthcare!

HEME is an innovative software and application development company targeting the healthcare technology market.

Healthcare technology plays a huge role in the healthcare industry. One of the most critical components of a successful clinic or hospital is how they manage accessibility to information.

According to Compass Intelligence, the U.S. market for health information technology
will expand to $85 billion in 2014 from an estimated $73.1 billion this year,
representing a 4.5 percent compound annual growth rate!


HEME's goal is to create products that will change the way the healthcare industry communicates through the use of advanced hardware and software programs.

HEME has two products: Virtual Vantage and Neuro Vantage.

Just last month HEME announced that Neuro Vantage is now being supported by Facebook!

This is significant news considering that Facebook is used by 500 million people in 70 different languages!

Neuro Vantage, based on plug-in architecture, will allow internet users with physical disabilities to utilize Facebook.

NEVER BEFORE have disabled individuals been able to neurally communicate and interact with a platform such as Facebook!

You can read the PR here:
http://finance.yahoo.com/news/Facebook-Now-Offering-iw-2240996128.html?x=0&.v=1



HEME currently trades at around: $0.04


Even Google and Bing are helping launch and offer HEME's Neuro Vantage!

HEME's technical software, based on plug-in architecture, will allow internet users with physical disabilities to utilize Google and its functionalities.

Disabled individuals will now be able to search, surf, and manipulate all the features of Google's search engine!

Healthcare is a tremendous market and HEME has an opportunity to capitalize on this multitrillion dollar industry with their line of products.

HEME has developed remote access software that allows communication between Apple's iPad and stationary computers!!

Since it's launch in April 2010, the iPad has been a huge hit.

Apple has sold more than 7 million iPads already!

HEME's software - Virtual Vantage - allows the iPad device to communicate directly with a desktop pc or server.

This software was created to support the vital overhaul expected of the healthcare industry.

The software can be used in healthcare facilities such as hospitals, doctor offices, clinics and pre and post patient care facilities. This is a big market!

HEME anticipates that the phenomenal sales of Apple's iPad will be the driving force of software sales for products like Virtual Vantage.

Wall Street analysts recently reported iPad sales expectations
of
28 million by 2011 and 57 million by 2015!


Healthcare Information Technology studies have revealed that 20% of healthcare professionals plan to incorporate the iPad into their practice!

HEME's product will allow records to be electronically created and stored. It will also reduce the required manpower for pushing paper, which will create an environment for more accurate record keeping, thus decreasing lawsuits in a litigious society.

Most importantly, the software will free up more time for healthcare professionals, allowing their time to be better spent with clients or family.

HEME believes the Virtual Vantage software can create an opportunity for hospitals, doctor's offices and staff work more resourcefully and efficiently.

Check out this interesting article on how the iPad is changing healthcare:
http://www.businessinsider.com/10-ways-the-ipad-is-changing-healthcare-2010-7#apps-for-surgery-1

It's amazing how much an iPad is capable of doing in the healthcare sector!



         We are giving a STRONG ALERT on HEME to our Members!
 
Below you will see why we think HEMI could be our next huge gainer!



****It is expected that healthcare spending in general could reach 4.5 trillion by 2019!****

****President Obama has pledged 630 billion dollars to the healthcare industry in an attempt to overhaul, modernize and transform the industry!!****

****The tablet market is supposed to hit 100 million units by 2013, according to research from DigiTimes.****

****According to Juniper Research, spending on mobile hardware, software and services across the global healthcare sector is set to rise to $2.7 billion in 2010!****

****1 in 5 Medical Professionals worldwide will upgrade their management technology with products like Virtual Vantage!****



President Obama has committed to transforming the healthcare industry in the US.

Take a look at President Obama's speech on healthcare reform on YouTube: http://www.youtube.com/watch?v=uG3IJazP5gk&feature=player_embedded

Regarding the healthcare industry, President Obama has pledged 630 billion dollars over the next 10 years to the industry!

The US American Recovery and Reinvestment Act of 2009 has ALREADY awarded 70 billion dollars through the US Department of Health and Human Services to the healthcare industry.

The current Administration announced that $19 billion has been set aside for health-information technology spending.

It has been reported hospitals could receive as much as $11 million each. Physicians may also individually receive bonuses of between $44,000 and $64,000 if they can demonstrate computerization of their medical-records.

HEME
CFO Dale Paisley commented, "Digitized medical records place the healthcare industry in a position to improve the quality of patient care through healthcare professionals. This service will also support the use of modern medical applications, innovative software and new technology."

"Healthmed believes Virtual Vantage will transform the industry and will be supported by these stimulus funds. Healthmed also believes that their unique line of innovations, will not only revolutionize specific aspect on the Health care industry, but also position the company for a significant market share," Paisley also said.

The fact that Apple's iPad can be used as a key tool for health care could be a very strong driving sales factor for HEME.

According to a new market research survey, the health care sector was the third readiest adopter of the tablet technology, behind the high tech and financial services sectors!

"We believe these industries are embracing the iPad because its unique design makes it easier to perform time-sensitive, mission-critical tasks," John Herrema, senior vice president of corporate strategy with Good Technology.



About HEME:


http://www.healthmedltd.com/


Healthmed Services, Ltd. (OTCPK: HEME) is an innovative software development company.

HEME's objective is to utilize communications technology to provide individuals, companies and health-provider organizations optimal products and services to increase the productivity and efficiency of professionals in the healthcare industry.

HEME's longtime goal has been to provide healthcare organizations greater use of technology through optimal hardware and software solutions.

The Company is currently creating products that increase efficiency and communication within the healthcare industry.

HEME will eventually offer server and network solutions to health provider organizations as well as remote access via handheld devices such as the iPad for healthcare professionals.

A recently published report from PricewaterhouseCoopers points out that healthcare is "playing catch-up" when it comes to innovation, especially technological.

It says the ubiquity of wireless mobile devices such as smart phones creates both an opportunity and a need for medical practitioners to overhaul how they deliver medical care.


HEME's goals and product ideas fit the needs of the healthcare industry and its professionals.

HEME Director John Popovic recently commented, "Virtual Vantage will revolutionize the management of medicine. The development of progressive technologies such as the iPad has created software opportunities that medical professional desire."

HEME feels optimistic that Virtual Vantage software coupled with medical applications available to iPad users will simplify healthcare professionals' practices, allowing them more free time in this multi-billion dollar sector!




HEME looks like a golden opportunity at these levels!

Keep HEME on your Radar Screen for more news and action on the stock!

HEME could be the Next EXPLOSIVE Stock !!!






-PennyPic



GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY
We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.  PennyPic.com's sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by PennyPic.com or an offer or solicitation to buy or sell any security.  Neither the owner of PennyPic.com nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.   It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit
PennyPic.com. PennyPic.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.

Please be advised that PennyPic.com has been paid one hundred thousand dollars by heiwa international corp this is for marketing and advertising services for a one week profile of healthmed services ltd which services include the issuance of this release and the other opinions that we release concerning heme. PennyPic.com has not investigated the background of heme the hiring company. Anyone viewing this newsletter should assume the hiring party or affiliates of the hiring party own shares of heme of which they plan to liquidate, further understanding that the liquidation of those shares may or may not negatively impact the share price. PennyPic.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding heme. PennyPic.com is owned by: Pudong, LLC, Questions regarding this release may be sent to PennyPic@PennyPic.com.

Notice of Stock Price Movements and Volatility
Viewers of this newsletter should understand that trading activity and stock prices in many if not all cases tend to increase during the advertisement campaigns of the profiled companies and in many if not all cases tend to decrease thereafter. This tends to create above average volatility and price movements in the profiled company during the advertisement campaign that viewers should take into consideration at all times. Campaigns vary in length, and many are for short periods of time, typically less than a week.

Notice of Affiliated and Non-Affiliated Newsletters
PennyPic.com regularly shares research with two affiliated newsletters (“Affiliated Newsletters”) whose services have been retained to profile healthmed services ltd “heme” during PennyPic.com’s profile period.  PennyPic regularly coordinates the timing of the dissemination of its research reports with the two Affiliated Newsletters. It is also possible that other newsletters or profiles have been created by sources we are unaware of. Viewers should take this into consideration when viewing any increased interest in healthmed services ltd “heme”.

Some of the content in this release contains f orward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look f orward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any f orward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.

Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. More information can be received from the advertised companies' website
www.healthmedltd.com Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") website www.sec.gov and the Financial Industry Regulatory Authority ("FINRA") website at www.finra.org.   Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PennyPic.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and PennyPic.com has no obligation to update any of the information provided. PennyPic.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.

From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. PennyPic.com encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

This release may provide hyperlinks to third party websites or access to third party content. PennyPic.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does PennyPic.com control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that PennyPic.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that PennyPic.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

PennyPic.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.

You agree to hold PennyPic.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk.  PennyPic.com disclaims all warranties of any kind, express or implied.

We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at
www.investor.gov and filings made by public companies can be viewed at www.sec.gov  and/or then FINRA at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm.



This message was sent from PennyPic to Subscriber. It was sent from: Penny Pic, 900 North Federal High Way, Boca Raton, Fl 33432. You can modify/update your subscription via the link below.

Email Marketing by
iContact - Try It Free!


 

Leave a Reply

You must be logged in to post a comment.

Partly powered by CleverPlugins.com